PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | |cirrhosis |
| Sentences | 120 |
| PubMedID- 25861432 | Occult hepatitis b infection in patients with cryptogenic liver cirrhosis in southwest of iran. |
| PubMedID- 25295102 | The presence of liver cirrhosis due to hepatitis b virus, which was identified 10 years previously, and the clinical appearance caused mfh to appear as hepatocellular carcinoma at the time of the initial diagnosis. |
| PubMedID- 23801819 | Subsequent investigations revealed the presence of hepatitis b with secondary liver cirrhosis, complicated by portal hypertension and esophageal varices. |
| PubMedID- 24133502 | Chronic hepatitis b (chb) is associated with chronic hepatitis, cirrhosis, and hepatocellular carcinoma (hcc; mcmahon, 2009). |
| PubMedID- 23053891 | A meta-analysis of nucleos(t)ide analogues in patients with decompensated cirrhosis due to hepatitis b. |
| PubMedID- 22967105 | Patients with decompensated cirrhosis owing to chronic hepatitis b viral (hbv) infection have a high morbidity/mortality rate, and the treatment remains a challenge. |
| PubMedID- 26579446 | The annual incidence rates of liver failure (decompensation), hcc, and death in patients with cirrhosis associated with chronic hepatitis b or c infection are approximately 4%, 3% and 3%, respectively1. |
| PubMedID- 26097877 | Liver cirrhosis on the basis of a chronic hepatitis b or c, autoimmune hepatitis, chronic alcohol abuse, primary sclerosis cholangitis and primary biliary cirrhosis are only few of the possible reasons for liver failure. |
| PubMedID- 25691846 | Patients with liver cirrhosis due to hepatitis b or hepatitis c, nonalcoholic steatohepatitis, and autoimmune liver diseases were also not included. |
| PubMedID- 26213498 | Tlr4 may be involved in the immune response in liver disease caused by hepatitis b, which can lead to inflammation, cirrhosis, and hepatocellular carcinoma . |
| PubMedID- 20357999 | We evaluated the effect of tgf-β1 gene polymorphism at codon 10 on the development of cirrhosis in patients with chronic hepatitis b. |
| PubMedID- 21912436 | Objectives: routine screening for hepatocellular carcinoma (hcc) is recommended in chronic hepatitis b (hbv) patients with cirrhosis and select non-cirrhotic hbv populations including asian males ages 40 and older and females ages 50 and older. |
| PubMedID- 20642705 | Risk factors for the development of hcc have been well documented and include the presence of cirrhosis, infection with hepatitis b and c viruses, heavy alcohol intake, diabetes and obesity (1,2). |
| PubMedID- 26222818 | Objective: to determine the associations of liver lobe-based magnetic resonance diffusion-weighted imaging findings using multiple b values with the presence and child-pugh class of cirrhosis in patients with hepatitis b. |
| PubMedID- 25903030 | Analysis by cox proportional hazard regression revealed that tb increased the risk of cirrhosis in patients with either hepatitis b (adjusted hr = 1.91; 95% ci = 1.05-3.47) or hepatitis c (adjusted hr = 2.56; 95% ci = 1.37-4.78). |
| PubMedID- 23050258 | The perinatal history indicated that her mother was a hbv carrier, and grandmother died of cirrhosis due to chronic hepatitis b. the patient was vaginally born, and was immunized with hepatitis b vaccine and high-titter immunoglobulin against hbv at birth. |
| PubMedID- 24640680 | All patients with liver cirrhosis in the outcome of replication-phase chronic hepatitis b need antiviral therapy. |
| PubMedID- 25040685 | Hepatocellular carcinoma risk in hbeag-negative chronic hepatitis b patients with or without cirrhosis treated with entecavir: hepnet.greece cohort. |
| PubMedID- 24649471 | A 71-year-old woman with a history of diabetes mellitus and liver cirrhosis associated with hepatitis b viral infection was hospitalized for right lower lobe lobectomy after diagnosis of lung cancer. |
| PubMedID- 21110434 | Objective: to study the association of the cd4+ cell counts and hbeag with liver damage and cirrhosis in patients with chronic hepatitis b (chb). |
| PubMedID- 23133573 | Each year, 300,000 deaths are attributed to chronic hepatitis b, including deaths associated with liver cirrhosis and hepatocellular carcinoma (hcc) 2. |
| PubMedID- 19500972 | Fifty nine patients had background cirrhosis due to hepatitis b, c or other reason and preserved liver function (child a). |
| PubMedID- 25409662 | Indications for liver transplantation included liver cirrhosis associated with hepatitis b (n=9), hepatocellular carcinoma (n=6), alcoholic liver cirrhosis (n=2), cryptogenic liver cirrhosis (n=1), alagille syndrome (n=1), and wilson disease (n=1). |
| PubMedID- 23173703 | Hcc is closely associated with chronic liver disease, particularly cirrhosis due to hepatitis b virus or hepatitis c virus infection . |
| PubMedID- 24707821 | Multi-tgdr, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis b or hepatitis c virus. |
| PubMedID- 25283312 | Reported that chronic hepatitis b without cirrhosis is not associated with type 2 diabetes mellitus.20 kumar et al. |
| PubMedID- 25963803 | Controversy exists about whether antiviral therapy (avt) should be recommended for compensated cirrhosis patients with chronic hepatitis b virus (hbv) infection and detectable, but low, serum hbv-dna levels. |
| PubMedID- 23006433 | Prediction of significant fibrosis and cirrhosis in hepatitis b e-antigen negative patients with chronic hepatitis b using routine parameters. |
| PubMedID- 22977309 | Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis b in patients with decompensated cirrhosis from a third-party us payer perspective. |
| PubMedID- 24921210 | cirrhosis regression in patients with viral hepatitis b and c: a systematic review. |
| PubMedID- 25861254 | Chronic pruritus is more frequently seen in intrahepatic cholestatic diseases such as primary biliary cirrhosis (pbc), intrahepatic cholestasis of pregnancy, chronic hepatitis b and c, familial intrahepatic cholestasis, and alagille syndrome. |
| PubMedID- 24867511 | Results: several studies have proven the efficacy and safety of entecavir in the treatment of patients affected by complex forms of hepatitis b, as those with decompensated cirrhosis, exacerbations of hbv infection and fulminant hepatic failure or in transplanted subjects. |
| PubMedID- 26110141 | Chronic hepatitis b (chb) is associated with cirrhosis and hepatocellular carcinoma (hcc) in patients suffering from congenital and/or acquired immunodeficiency and also following immunosuppressive therapy. |
| PubMedID- 26420029 | A 55-year-old man was admitted to a hospital in suphanburi province, a central region in thailand on december 8, 2012. he had an underlying condition with liver cirrhosis from a history of hepatitis b infection and alcohol misuse. |
| PubMedID- 21270118 | Virological suppression does not prevent the development of hepatocellular carcinoma in hbeag-negative chronic hepatitis b patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide hepnet. |
| PubMedID- 26494948 | Based upon the improved survival of liver cirrhosis patients infected with hepatitis b and c viruses, surveillance with imaging studies with every six months, compared to that with longer intervals or no examination, has been recommended for the early hcc discovery in chronic liver disease patients though the importance of the semiannual surveillance has not been established in nbnc-chronic liver disease patients . |
| PubMedID- 24827653 | A 60-year-old patient with cirrhosis due to chronic hepatitis b was admitted to the hospital for routine controls. |
| PubMedID- 23051943 | Materials and methods: thirty-four patients of cc and 32 patients having cirrhosis due to chronic hepatitis b (hep b) were assessed in a cross-sectional study in a tertiary hospital for insulin resistance, % beta-cell activity, obesity indices, plasma glucose, lipid profiles, and many other parameters. |
| PubMedID- 23376798 | Background & aims: hepatitis delta virus (hdv) infection causes fulminant hepatitis and increases the severity of chronic hepatitis b virus infection, leading to cirrhosis, liver failure, or hepatocellular carcinoma. |
| PubMedID- 20492510 | A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis b patients. |
| PubMedID- 24716215 | Methods: we consecutively enrolled 88 chronic hepatitis b patients with compensated cirrhosis primarily treated with ldt at least for 2 years or less than 2 years but developed resistance, and evaluated the efficacy and clinical outcomes. |
| PubMedID- 25821463 | Patients were excluded if they had hcv genotype other than type 1 infection (i.e., hcv types 2–6), biopsy-proven cirrhosis, other causes of liver disease, hepatitis b virus infection, human immunodeficiency virus infection, autoimmune disorders, clinically significant cardiac or cardiovascular abnormalities, organ grafts, systemic infections, clinically significant bleeding disorders, evidence of malignant neoplastic diseases, concomitant immunosuppressive medication, fasting glucose levels >7 mmol/l or glucose levels >11.1 mmol/l at 2 hours after an oral intake of 75 grams of glucose (oral glucose tolerance test) or glycosylated hemoglobin > 48 mmol/mol (6.5%) or antidiabetic treatment, or any alcohol intake or drug abuse within the six months prior to study entry. |
| PubMedID- 26100495 | Background & aims: esophageal varices (ev) are a marker of disease severity in compensated cirrhosis due to hepatitis b virus (hbv) which predicts also the risk of hepatocellular carcinoma (hcc), clinical decompensation and anticipated liver related death. |
| PubMedID- PMC3580826 | Lamivudine has been shown to be very efficacious in treatment of hepatitis b in patients with decompensated cirrhosis and improvement of liver failure, but is aggravated by a high incidence of virologic breakthrough due to resistance, up to 53% in patients with cirrhosis after 48 months, with the risk of rapid decompensation and even death due to the virologic breakthrough (16). |
| PubMedID- 22375524 | This review article provides an overview of currently available data on regression of fibrosis and cirrhosis in patients with chronic hepatitis b treated with nucleoside and nucleotide analog inhibitors of hbv. |
| PubMedID- 25531375 | Objective: to evaluate the efficacy of nucleos(t)ide analogues (na) treatment and to assess the long-term outcomes, including survival, liver function improvement and virologic response, in patients with decompensated cirrhosis due to hepatitis b virus (hbv) infection. |
| PubMedID- 23549624 | Is regression of cirrhosis in patients with hepatitis b infection possible. |
| PubMedID- 22841263 | An 18-year-old male living donor for his father with end-stage liver cirrhosis due to hepatitis b underwent an extended right lobe donor hepatectomy. |
| PubMedID- 21191876 | Immunisation against hepatitis b in persons with liver cirrhosis is associated with a poor response and new vaccines should be considered for these patients. |
| PubMedID- 25760884 | Furthermore, circulating opn level is characterized as an excellent predictor of cirrhosis in patients with hepatitis b infection . |